Allergic Conjunctivitis
📧 Sign up to get email alerts when something new happens for Allergic Conjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-20Clinical Trial Update: Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis [Phase 2]
Phase 2 trial assessing different concentrations of SPARC1102 for allergic conjunctivitis has completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis [Phase 2]
Phase 2 study of OTX-DP for chronic allergic conjunctivitis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis [Phase 3]
Phase 3 clinical trial update for AGN-229666 ophthalmic solution in Japanese patients with allergic conjunctivitis has completed with result…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis [Phase 3]
A Phase 3 clinical trial update for a multi-center environmental treatment of moderate to severe ocular allergic conjunctivitis has complete…
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft
Completed clinical trial comparing patient-reported ocular comfort between Bepreve and Lastacaft in allergic conjunctivitis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy [Phase 2]
A Phase 2 randomized trial evaluating a novel method of specific allergen immunotherapy for grass pollen-induced rhinoconjunctivitis has com…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis
A pilot clinical trial evaluated a cutaneous antigen neutralization test in patients with rhinoconjunctivitis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts [Phase 3]
A Phase 3 multicenter clinical trial is evaluating the safety and efficacy of specific immunotherapy using modified allergen extracts for al…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children [Phase 3]
A multicenter Phase 3 trial evaluating sublingual grass pollen allergen extract for children with allergic rhinoconjunctivitis has completed…
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel
This clinical trial update notes that the Ambrosia-related study in Israel addressing allergic rhinitis and asthma has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-06Clinical Trial Update: Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis [Phase 2]
Phase 2 safety and efficacy study of AL-53817 and AL-78843 ophthalmic solutions for allergic conjunctivitis has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense [Phase 2]
Phase 2 trial comparing different up-dosing schedules of Osiris Phleum Pratense (timothy grass pollen extract) for allergic rhinitis with co…
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: Vitamin D and Grass Pollen Specific Immunotherapy [Phase 2]
Phase 2 trial evaluating vitamin D as an adjunct to grass pollen-specific immunotherapy for allergic rhinoconjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients [Phase 4]
Phase 4 clinical evaluation of 0.1% olopatadine hydrochloride ophthalmic solution in pediatric patients for allergic conjunctivitis has been…
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: Safety and Comfort of AL-4943A Ophthalmic Solution [Phase 1]
Phase 1 trial update assessing safety and comfort of AL-4943A ophthalmic solution for allergic conjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers [Phase 3]
A Phase 3 safety study of an ophthalmic solution for allergic conjunctivitis completed in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan [Phase 4]
Phase 4 trial in Japan evaluating the effectiveness of olopatadine HCl ophthalmic solution for allergic conjunctivitis has completed and res…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis [Phase 3]
Phase 3 study of DE-114 ophthalmic solution for allergic conjunctivitis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-09-23Clinical Trial Update: A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis [Phase 3]
This document reports the completed Phase 3 long-term study of DE-114 Ophthalmic Solution for allergic conjunctivitis, with results posted i…
-
CLINICAL_TRIALS trial_result · 2014-08-18Clinical Trial Update: Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients [Phase 4]
A Phase 4 clinical trial by Alcon Research evaluated corneal structures in symptomatic allergic conjunctivitis patients using confocal analy…
-
CLINICAL_TRIALS trial_result · 2014-08-11Clinical Trial Update: Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of an ophthalmic solution in patients with allergic conjunctivitis. The results we…
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis [Phase 3]
An open-label, long-term Phase 3 study evaluating AL-4943A ophthalmic solution, 0.2%, in allergic conjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects [Phase 3]
Phase 3 trial evaluating olopatadine hydrochloride ophthalmic solution versus vehicle in Japanese subjects with acute allergic conjunctiviti…
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation [Phase 2]
Alcon Research completed a Phase 2 clinical trial evaluating AL-38583 Ophthalmic Solution for allergic conjunctivitis with inflammation.
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED) [Phase 2, Phase 3]
Completed Phase 2/3 trial evaluating the efficacy and long-term safety of a ragweed pollen sublingual tablet in adults with ragweed-induced …